Disordered Porphyrin Metabolism: A Potential Biological Marker for Autism Risk Assessment.  Heyer NJ, Echeverria D, Woods JS.Autism Res. 2012 Feb 1. doi: 10.1002/aur.236.


Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia. Al-Yafee YA, Al-Ayadhi LY, Haq SH, El-Ansary AK. BMC Neurol. 2011 Nov 4;11:139.


Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results. Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr J.BMC Clin Pharmacol. 2009 Oct 23;9:16.


Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results. Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr J.  BMC Clin Pharmacol. 2009 Oct 23;9:17.

The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels.  Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Da hr JM.  J Toxicol. 2009;2009:532640. Epub 2009 Aug 26.

  •